DRI to seek $1bn for third fund
The Toronto-based firm, which focuses on pharmaceutical royalties, has been busy since closing its second fund on $701m in 2010.
17 January 2013•3 mins read
The Toronto-based firm, which focuses on pharmaceutical royalties, has been busy since closing its second fund on $701m in 2010.
The largest funds take a growing share of total PE fundraising
29 October 2026 · 2 mins read
Side Letter: Mid-alignment
29 October 2026 · 3 mins read
Side Letter: Software stress
28 October 2026 · 3 mins read
Ardian bets on the ‘power of live’ in latest buyout fund
28 October 2026 · 3 mins read
Advent’s $27bn flagship: How it stacks up against PE’s biggest funds
27 October 2026 · 2 mins read
Apax eyes March 2027 first close for Fund XII
27 October 2026 · 2 mins read
Side Letter: Roads less traveled
27 October 2026 · 5 mins read
